A vs B [Design Issues]

posted by mittyri – Russia, 2020-02-03 22:05 (1394 d 12:29 ago) – Posting: # 21136
Views: 2,825

Hi John,

citing our Hero:

If one is really interested in λz and has no SD-phase in the study, sampling should continue until concentrations from previous doses are washed out – I would expect any estimate within the MD-profile to be biased towards faster elimination.

❝ I have seen both designs but I (and my former bosses) prefer method A. The only drawback I see from A is it takes longer time.

why does A take longer time?

Edit: Changed to internal link; see also this post #7[Helmut]

Kind regards,

Complete thread:

UA Flag
 Admin contact
22,811 posts in 4,783 threads, 1,642 registered users;
12 visitors (0 registered, 12 guests [including 2 identified bots]).
Forum time: 10:34 CET (Europe/Vienna)

Every man gets a narrower and narrower field of knowledge
in which he must be an expert in order to compete with other people.
The specialist knows more and more about less and less
and finally knows everything about nothing.    Konrad Lorenz

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz